pentamidine has been researched along with Cough in 8 studies
Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.
Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
Excerpt | Relevance | Reference |
---|---|---|
"Four patients who coughed during AP administration were pretreated with 10 mg metaproterenol aerosol prior to a second inhalation of AP." | 9.07 | Bronchodilator pretreatment improves aerosol deposition uniformity in HIV-positive patients who cough while inhaling aerosolized pentamidine. ( Harrison, KS; Laube, BL, 1994) |
"15 patients with first episodes of Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome were treated with only aerosolised pentamidine, which they inhaled for 20 minutes every day for 21 days." | 7.67 | Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. ( Brunette, EN; Corkery, KJ; Debs, RJ; Hopewell, PC; Lin, ET; Luce, JM; Montgomery, AB; Turner, J, 1987) |
"Four patients who coughed during AP administration were pretreated with 10 mg metaproterenol aerosol prior to a second inhalation of AP." | 5.07 | Bronchodilator pretreatment improves aerosol deposition uniformity in HIV-positive patients who cough while inhaling aerosolized pentamidine. ( Harrison, KS; Laube, BL, 1994) |
"To assess the safety and efficacy of aerosol pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome (AIDS)." | 5.07 | Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study. ( Chan, CK; Falutz, JM; Fong, IW; Gervais, A; Hyland, RH; Lawson, LM; MacFadden, D; Montaner, JS; Rachlis, AR; Renzi, PM, 1991) |
" Cough-reduction measures should be taken when giving pentamidine aerosol, and patients who do cough should cover their mouths." | 4.78 | Control of tuberculosis during aerosol therapy administration. ( Chaisson, RE; McAvinue, S, 1991) |
"15 patients with first episodes of Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome were treated with only aerosolised pentamidine, which they inhaled for 20 minutes every day for 21 days." | 3.67 | Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. ( Brunette, EN; Corkery, KJ; Debs, RJ; Hopewell, PC; Lin, ET; Luce, JM; Montgomery, AB; Turner, J, 1987) |
"Nine patients with AIDS were studied using three nebulizer systems producing different droplet size profiles: the Acorn System 22, Respirgard II, and Respirgard II with the inspiratory baffle removed." | 2.67 | Alveolar targeting of aerosol pentamidine. Toward a rational delivery system. ( Clarke, SW; Johnson, MA; Lee, CA; Newman, SP; Simonds, AK; Talaee, N, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 7 (87.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harrison, KS | 1 |
Laube, BL | 1 |
Chaisson, RE | 1 |
McAvinue, S | 1 |
O'Riordan, TG | 1 |
Smaldone, GC | 1 |
Doré, MF | 1 |
Bréchot, JM | 1 |
Orvoën-Frija, E | 1 |
Poubeau, P | 1 |
Rochemaure, J | 1 |
Montaner, JS | 1 |
Lawson, LM | 1 |
Gervais, A | 1 |
Hyland, RH | 1 |
Chan, CK | 1 |
Falutz, JM | 1 |
Renzi, PM | 1 |
MacFadden, D | 1 |
Rachlis, AR | 1 |
Fong, IW | 1 |
Simonds, AK | 1 |
Newman, SP | 1 |
Johnson, MA | 1 |
Talaee, N | 1 |
Lee, CA | 1 |
Clarke, SW | 1 |
Montgomery, AB | 1 |
Debs, RJ | 1 |
Luce, JM | 1 |
Corkery, KJ | 1 |
Turner, J | 1 |
Brunette, EN | 1 |
Lin, ET | 1 |
Hopewell, PC | 1 |
1 review available for pentamidine and Cough
Article | Year |
---|---|
Control of tuberculosis during aerosol therapy administration.
Topics: Aerosols; Cough; Cross Infection; HIV Infections; Humans; Nebulizers and Vaporizers; Pentamidine; Pe | 1991 |
4 trials available for pentamidine and Cough
Article | Year |
---|---|
Bronchodilator pretreatment improves aerosol deposition uniformity in HIV-positive patients who cough while inhaling aerosolized pentamidine.
Topics: Adult; Aerosols; Cough; Female; Gamma Cameras; HIV Seropositivity; Humans; Lung; Male; Metaprotereno | 1994 |
Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aerosols; Bronchial Spasm; Cough; Female; Follow-Up Studi | 1991 |
Acute pulmonary effects of aerosolized pentamidine. A randomized controlled study. Toronto Aerosolized Pentamidine Study (TAPS) Group.
Topics: Adult; Aerosols; Bronchial Spasm; Cough; Double-Blind Method; Female; Humans; Lung; Male; Pentamidin | 1990 |
Alveolar targeting of aerosol pentamidine. Toward a rational delivery system.
Topics: Acquired Immunodeficiency Syndrome; Administration, Inhalation; Adult; Aerosols; Cough; Humans; Male | 1990 |
3 other studies available for pentamidine and Cough
Article | Year |
---|---|
Exposure of health care workers to aerosolized pentamidine.
Topics: Aerosols; Air Pollutants, Occupational; Chromatography, High Pressure Liquid; Cough; HIV Infections; | 1992 |
Acute pulmonary effects of aerosolized pentamidine.
Topics: Aerosols; Bronchial Spasm; Cough; Humans; Pentamidine; Pneumonia, Pneumocystis | 1991 |
Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Aerosols; Amidines; Cough; Drug Evaluation; Follow-U | 1987 |